SS
Scott E Smith
Director

Scott E Smith insider trades: ProUroCare Medical (PUMD) stock purchases

Director, ProUroCare Medical Last trade Jul 1, 2010 31 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2006
3
Companies
last trade 2010

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Scott reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 1, 2010PUMD↑ Buy$8K
Dec 29, 2009TBTC.OB↑ Buy$3K
Dec 21, 2009TBTC.OB↑ Buy$22K
Dec 17, 2009TBTC.OB↑ Buy$4K
Nov 9, 2009PUMD↑ Buy$1K
Apr 13, 2009PUMD↑ Buy$6K
Jul 11, 2008PRRC↑ Buy$6K
Sep 10, 2007PRRC↑ Buy$3K
Feb 9, 2007PRRC↑ Buy$7K
Sep 7, 2006PRRC↑ Buy$25K
May 26, 2006PRRC↑ Buy$9K
May 25, 2006PRRC↑ Buy$34K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Scott E Smith's insider trades

Scott E Smith is a director at ProUroCare Medical (PUMD). Since May 25, 2006, Scott has reported 12 open-market purchases worth $128K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (17 filings), other transactions (5 filings), option exercises (2 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PUMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.